Removing Pediatric OTC Cold Drugs Would Create New Problems – CHPA
This article was originally published in The Tan Sheet
Executive Summary
Pulling pediatric cough/cold products off the shelf in an effort to curb adverse events could lead to "unintended" consequences, such as parents inappropriately giving children adult medication, according to results of a Consumer Healthcare Products Association study
You may also be interested in...
Calls For Cough/Cold Collaboration As FDA Inches Toward Rulemaking
As FDA embarks on a lengthy rulemaking process to address pediatric OTC cough/cold products, the agency has strategies outside the regulatory framework available to effect any more immediate changes it deems necessary
Calls For Cough/Cold Collaboration As FDA Inches Toward Rulemaking
As FDA embarks on a lengthy rulemaking process to address pediatric OTC cough/cold products, the agency has strategies outside the regulatory framework available to effect any more immediate changes it deems necessary
Calls For Cough/Cold Collaboration As FDA Inches Toward Rulemaking
As FDA embarks on a lengthy rulemaking process to address pediatric OTC cough/cold products, the agency has strategies outside the regulatory framework available to effect any more immediate changes it deems necessary